Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otovowen for Prevention of AOM in Children
NCT02345447Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Otovowen in acute otitis media (AOM), sponsored by University Hospital Tübingen. Started Oct 2013; status: completed.
02
Drugs
Otovowen
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT02345447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02345447.